Clinical Laboratory Services Market Size By Test Type (Human & Tumor Genetics, Clinical Chemistry {Routine Chemistry Testing, Specialized Chemistry Testing, Therapeutic Drug Monitoring (TDM) Testing, Endocrinology Chemistry Testing}, Medical Microbiology & Cytology, Other Esoteric Test), By Service Provider (Hospital-based Laboratories, Stand-alone Laboratories, Clinic-based Laboratories), Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2020 - 2026

Published Date: Dec 2020  |  Report ID: GMI807  |  Authors: Sumant Ugalmugle, Rupali Swain

Report Format: PDF   |   Pages: 165   |   Base Year: 2019

Summary Table of Contents Industry Coverage Methodology

Industry trends

Clinical Laboratory Services Market size was valued at over USD 249 billion in 2019 and is expected to grow at a CAGR of more than 3.9% between 2020 and 2026. Clinical laboratory services are designed to deliver information and services to maximize the effective diagnosis, treatment and care, thereby reducing the complexity of current healthcare system. The information based on clinical laboratory services enables healthcare professionals to make accurate therapeutic and evidence-based diagnostic decisions for the patients.

Clinical Laboratory Services Market Overview

Get more details on this report - Request Free Sample PDF

Rising geriatric population pool that is prone to various chronic conditions in developed as well as developing countries has stimulated the demand for clinical laboratory services. As per the U.S. Census Bureau, in mid-2019, there were over 54 million Americans in the age group of 65 years and above. This population is poised to reach more than 83 million by 2040. Majority of the people among this age group suffer from chronic diseases and infections that will spur the adoption of clinical tests.

The COVID-19 pandemic will have a moderate to high impact on the global market. COVID-19 infection is a respiratory disease and has affected millions of lives around the globe. Increasing cases of COVID-19 infected patients across the globe has led to a rise in clinical chemistry services, especially in specialized chemistry testing segment. Laboratory testing demands have increased significantly and continues to grow at a staggering rate in an attempt to keep pace with suspected cases of COVID-19, thus boosting the industry growth.

Growing awareness among people regarding disease management and early diagnosis will fuel the market expansion

Increasing awareness among people regarding disease management along with early diagnosis will influence the industry progression. Availability of probable cure required for disease state coupled with advancements in tests will increase the demand for clinical tests. Moreover, emerging infectious ailments have the potential to cause substantial mortality, morbidity, and economic damage. Efforts undertaken for the prevention of emerging infectious ailments will further drive the market value over the forecast timeline.

Inadequate reimbursements rates may potentially restrain the clinical laboratory services market progression

Reimbursement rates associated with diagnostic lab tests vary widely and may potentially restrain the industry value over the coming years. As per the Infectious Diseases Society of America (IDSA) October 2017 report, there were concerns with the CMS method of data collection, leading to inapt new reimbursement rates resulting in reduced patient access to testing. Furthermore, one of the most common methods to control expenses of laboratory services is to reduce the reimbursement rate. This method can be effective in short run however, it has several disadvantages including irreducible cost to conduct any test, thereby restraining the industry expansion to some extent.

Rising number of cancer patients in U.S will increase the test acceptance and augment the market revenue

Clinical Laboratory Services Market Size

Get more details on this report - Request Free Sample PDF

The human & tumor genetic segment accounted for 23.7% of the market share in 2019. High prevalence of tumors and genetic disorders in pediatric population will upsurge the demand for these tests. For instance, it is estimated that around 174,250 people in the U.S. were diagnosed with leukemia in 2018. This is predicted to increase the usage of tumor testing that will in turn aid in the market demand. Also, analytical instruments have been developed that quantifies leukemia cancer and accurate diagnostic decisions enable better surgical performance, thereby fostering the segment growth.

Technologically advanced devices utilized for diagnosing diseases in stand-alone laboratories will positively impact the segment expansion

Stand-alone laboratories exceeded USD 103.5 billion in 2019 and is set to register growth of 4.4% by 2026. Increasing prevalence of rare genetic disorders will influence the demand for stand-alone laboratories that are well-equipped with technologically advanced medical devices. Esoteric testing enables detection and analysis of rare genes or molecules that are performed routinely in the clinical laboratories and genetic testing centers. Stand-alone laboratories perform testing of genetic diseases and are equipped with automated medical devices that aid in accurate and efficient detection.

Increasing prevalence of chronic disease among geriatric population in North America will propel the market growth

North America Clinical Laboratory Services Market

Get more details on this report - Request Free Sample PDF

North America clinical laboratory services market accounted for 38.9% of revenue share in 2019 led by the growing geriatric population suffering from chronic diseases. Elderly population in age group of 65 years and above suffer from chronic illness such as cancer and viral, bacterial and fungal infections that will accelerate demand for clinical laboratory test. Additionally, as per the Canadian Cancer Statistics, around 200,000 Canadians suffered from cancer and 80,000 died in 2017. This has led to an increase in acceptance of various test that detect cancer, thereby augmenting the industry demand. Furthermore, rising healthcare expenditure and fund accumulations in public healthcare system will escalate the regional growth.

Adoption of business strategies will pave growth opportunities for companies operating in the market

Prominent players operating in the market include Fresenius Medical Care, Laboratory Corporation of America Holdings (LabCorp), Quest Diagnostics and Eurofins Scientific. Acquisition, partnerships and collaboration are the most commonly adopted business strategies to sustain market position.

Some of the recent industry developments:

  • In September 2020, LabCorp announced strategic partnership with Infirmary Health to broaden laboratory services across healthcare systems in Alabama. This will lead to business expansion of the company in the region. Such collaborative initiatives will help the organization in the development of patient service centers.
  • In September 2020, Rocky Mountain Analytical, a subsidiary of LifeLabs, partnered with Genova Diagnostics aimed to enhance accessibility and affordability of Genova’s diagnostic testing for Canadian population. This collaboration will help the organization to broaden its customer base.

The clinical laboratory services market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2015 to 2026, for the following segments:

Market, By Test Type

  • Human & tumor genetics
  • Clinical chemistry
    • Routine chemistry testing
    • Specialized chemistry testing
    • Therapeutic drug monitoring (TDM) testing
    • Endocrinology chemistry testing
    • Other clinical chemistry testing
  • Medical microbiology & cytology
  • Other esoteric tests

Market, By Service Provider

  • Hospital-based laboratories
  • Stand-alone laboratories
  • clinic-based laboratories

The above information is provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
  • Latin America
    • Brazil
    • Mexico
  • Middle East & Africa
    • South Africa
    • Saudi Arabia


Frequently Asked Questions (FAQ) :

The industry share of clinical laboratory services was over USD 249.3 billion in 2019 and is anticipated to record more than 3.9% CAGR through 2026.
With the increased prevalence of tumors and genetic disorders among pediatric patients, the human and tumor genetic segment held over 23.7% market share in 2019.
The stand-alone labs reached USD 103.5 billion in 2019 and will register over 4.4% CAGR up to 2026 owing to the availability of advanced & automated medical devices.
North America held around 38.9% industry revenue share in 2019 with the rising number geriatric population prone to chronic diseases like cancer and viral infections.

Premium Report Details

  • Published Date: Dec 2020
  • Pages: 165
  • Tables: 163
  • Charts / Figures: 30
  • Companies covered: 15
  • Countries covered: 15

Get a report that explains COVID-19 impact on this market

Buy NowImmediate delivery available

Need a Discount? Get in touch with us for special pricing

Request Discount

 Connect with our sales team

Chat with us
We use cookies to enhance user experience. (Privacy Policy) X